Steffanie Strathdee

Education

University of Toronto.

Career

Epidemiology of Human Immunodeficiency Virus and hepatitis C among injecting drug users in Tijuana (El Cuete). Funded by National Institute on Drug Abuse grant R01 District Attorney 019829. Role: Principal Investigator

Epidemiology of Human Immunodeficiency Virus and hepatitis C among injecting drug users in Tijuana (Swine Flu supplement).

Funded by National Institute on Drug Abuse grant R01 DA019829-04S1.

Role: Principal Investigator

Epidemiologic study on changing Human Immunodeficiency Virus risks among FSW-IDUs on the Mexico-United States border (Mujer Mas Segura). Funded by National Institute on Drug Abuse grant R01 DA023877.

Role: Principal Investigator

Drug market characteristics: Antecedents and sequelae on the Mexico-United States border (Parashoots). Funded by National Institute on Drug Abuse grant R21 DA024381.

Role: Principal Investigator

Acquired Immune Deficiency Syndrome International Training Research Program (AITRP).

Funded by FIC & National Institute on Drug Abuse. Grant 1D43TW008633-01. Role: Principal Investigator

Center for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Minority Pipeline in Substance Abuse Research (CHAMPS). Funded by National Institute on Drug Abuse grant R25 District Attorney 025571.

Role: Principal Investigator

Hispanic Health Professional Training in Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and Associated Comorbidities in the United States-Mexico Border Region (HSHPS).

Funded by HSHPS & the Centers for Disease Control and Prevention. Role: Company-director

Training Program in Substance Use, Human Immunodeficiency Virus and Related Infections (T32).

Funded by National Institute on Drug Abuse grant T32 District Attorney 023356. Role: Principal Investigator

Strathdee’s work has been published in and covered by the popular media including The Financial Post, Maclean’s, Canadian Broadcasting Company, British Broadcasting Corporation’s The World, KPBS and Inside Mexico.

Achievements

• Strathdee has been awarded more than $30 million in funding to conduct research studies involving marginalized populations in Mexico. She received recognition for her many contributions to disease prevention through optimal research projects, including the Award for Leadership in International Collaboration from the National Institute on Drug Abuse in (2009). The Accol-Acquired Immune Deficiency Syndrome, Award for Best Science/Research Project in Vancouver (2007). National Health Research Developmental Program, Health Canada National Health Scholar Award (1998-1903). Dean’s Award, Faculty of Medicine, University of British Columbia (1997). 11th International Conference on Acquired Immune Deficiency Syndrome Young Investigators Award (1996). Canadian Association for Human Immunodeficiency Virus Research, Young Investigators Award in Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Research (1994). Department of Preventive Medicine & Biostatistics, University of Toronto, Randall Coates Epidemiology Prize (1993). Strathdee serves on the editorial board of many prestigious journals, including: Acquired Immune Deficiency Syndrome, Drug and Alcohol Dependence and Harm Reduction (online), and is a member of many advisory boards, including the National Advisory Board, the Committee on Hepatitis C and Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome, the Canadian Institutes for Health Research, and the United Nations Reference Group on Human Immunodeficiency Virus Prevention Among Injection Drug Users.